Excipient Compliance: Ph.Eur 11 Updates and Supplier Qualification Urgency

Apple’s Regulated Substances Specification: Setting the Standard for Specialty Chemicals

Apple’s Regulated Substances Specification is reshaping how specialty chemical suppliers design and certify products. By establishing strict limits on hazardous substances, it drives safer, more sustainable materials across the electronics supply chain. Companies that meet Apple’s standards demonstrate leadership in chemical compliance and product stewardship.

C&EN's Chemical Confidentiality Analysis: What TSCA CBI Claims Mean for Safety Transparency

CBI claims under TSCA protect legitimate confidential business information, but they can also complicate chemical risk assessments. Here's what procurement professionals should understand about confidentiality claims, hazard evaluation and supplier due diligence.

Indian Medical Device Polymer Inputs: Day Two Without Duty Waiver and What It Means for Procurement

India's medical device manufacturers have entered a new cost environment following the reinstatement of customs duty on key polymer inputs. Procurement teams should prepare for higher supplier quotations as the industry seeks government relief.

Pharmaceutical Solvents Under Regulatory Pressure: ICH Q3C Updates and Procurement Impact

Pharma Solvent Markets: DMF, Acetonitrile, and IPA as GLP-1 Production Ramps Up

DMF, acetonitrile, and IPA markets are entering a new demand cycle as GLP-1 API production scales globally. Pharmaceutical buyers should renegotiate solvent contracts now before rising peptide manufacturing demand tightens supply in H2 2026

TSCA 2026: Immediate Actions After Fee Authority Expiry

When the TSCA fee authority expires in 2026, chemical manufacturers, importers and compliance teams face a new set of obligations. This article outlines the urgent steps required to stay compliant, from PMN filing updates to EPA chemical review adjustments. Read on to ensure your operations remain uninterrupted.